Feed TFX
TF

Teleflex

TFX · NYSE

$125.67 +0.92% (+$1.15)
1M -9.97%
Market Cap $5.51B
P/E Ratio -
Div. Yield 1.09%
ROE 31.83%

Bulios Fair Price

$155.84

24.0% upside

Current Price

$125.67

Undervalued Fair Value Overvalued

According to Bulios Fair Price, TFX is currently undervalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Moderate
5/9
Valuation
87 /100
Cheap
P/S 2.12x
P/FCF 14.11x
P/B 1.90x
Growth
6 /100
Declining
Rev. growth 10.62%
Book val. growth 8.07%
FCF growth 2.27%
Profitability
51 /100
Moderate
Gross margin 53.77%
FCF margin 15.02%
Net margin 39.58%
Quality
6 /100
Poor
ROIC 1.30%
Asset turnover 0.38x
ROE 31.83%
Debt
47 /100
Moderate
Debt/Equity 0.99x
Int. coverage -2.85x
Current ratio 2.60x
Stability
40 /100
Moderate
Beta 0.81x
Profitable years 0
Rev. volatility 22.68%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about TFX
Online

About the company

Teleflex Incorporated (TFX) is an American company focused on the development, manufacturing, and distribution of innovative medical devices and products for surgery, anesthesia, cardiovascular care, respiratory therapy, and other fields. With a broad portfolio of products including surgical instruments, catheters, endoscopes, tubes, and ventilators, Teleflex is one of the leading suppliers of medical devices in the market. The company focuses on innovative design, reliability, and user-friendliness of its products to provide effective and safe solutions to physicians and patients. Teleflex also invests in research and development of new technologies and products to continuously improve healthcare and treatment procedures. Teleflex Incorporated (TFX) shares could be suitable for investors looking to invest in companies operating in the medical device sector with an emphasis on innovation, quality, and a wide range of products for various medical specialties.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Jason Weidman

Employees

15,500

Headquarters

Wayne

Upcoming events

05 NOV

Earnings

Upcoming earnings report

45d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.